hotspot -WSS

hotspot

author：hotspot 2025-09-03 12:09:40 - browse：17

A syringe is prepared at a clinic in Norristown, Pa., Dec. 7, 2021. The Environmental Protection Agency finalized a rule Thursday, March 14, 2024, imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes. ( — The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. Matt Rourke/Ap

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities had polluted the air unchecked for decades, leading to disproportionately high cancer risks in surrounding communities.

The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. The rule will require commercial sterilization facilities to monitor and submit proof of their reduced emissions. It aligns with the Biden administration’s greater mission to end cancer and commitment to environmental justice, the EPA said.

Ethylene oxide is the most frequently used sterilizing chemical for devices that can’t be exposed to steam. It’s used to sanitize 20 billion devices in the U.S. per year, such as pacemakers, catheters, and ventilators. But long-term exposure to the gas can cause breast cancer, non-Hodgkin’s lymphoma, lymphocytic leukemia, and myeloma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Stop Congress from blocking public access to science

WSS

CMS got Medicare Advantage quality rating wrong, judge rules

CRISPR base editing slashes cholesterol levels in monkeys

IVG is promising — but it won’t replace IVF quite yet

Data don't support strong claims for Covid

Sutter Health’s antitrust win overturned by appeals court

CMS got Medicare Advantage quality rating wrong, judge rules

focus

hotspot

hotspot

How to save PrEP access — and even expand it

Data don't support strong claims for Covid

Peter Hotez and the public health issue of online harassment

Study points to new risk in gene therapy death of Terry Horgan

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Senators tussle over abortion against the backdrop of a presidential campaign

United colonoscopy coverage change 'may cost lives,' doctors say

An outdated Medicare rule harms dementia patients with anxiety

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

European officials brace for rough respiratory virus season

hotspot

Anthony Fauci pushes back on GOP claims during Covid hearing

2023 Nobel Prize in Medicine goes to Karikó and Weissman

6 solutions to address cancer drug shortages and others

Eli Lilly’s Zepbound improved liver scarring in mid

Experts study whether long Covid risk adds up with each reinfection

European officials brace for rough respiratory virus season

entertainment

entertainment

explore

entertainment